A life-course approach to cardiovascular disease prevention

James A. de Lemos; Ann M Navar

doi:10.1038/s41591-022-01870-8

A life-course approach to cardiovascular disease prevention

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	Nature medicine
DOIs	https://doi.org/10.1038/s41591-022-01870-8
State	Accepted/In press - 2022

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1038/s41591-022-01870-8

Cite this

@article{f6c55b9c6b72404b878a60ea35d3baa0,

title = "A life-course approach to cardiovascular disease prevention",

author = "{de Lemos}, {James A.} and Navar, {Ann M}",

note = "Funding Information: J.A.d.L. has received personal fees for participating in steering or data safety monitoring committees from Amgen, Regeneron, Verve Therapeutics, Novo Nordisc, Eli Lilly and Astra Zeneca. A.M.N. has received funding for research to her institution from BMS, Esperion, Amgen, and Janssen, and personal fees from Amarin, Amgen, Astra Zeneca, BI, Bayer, CSL, Esperion, Janssen, Lilly, Sanofi, Regeneron, NovoNordisk, Novartis, New Amsterdam, and Pfizer.",

year = "2022",

doi = "10.1038/s41591-022-01870-8",

language = "English (US)",

journal = "Nature medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - A life-course approach to cardiovascular disease prevention

AU - de Lemos, James A.

AU - Navar, Ann M

N1 - Funding Information: J.A.d.L. has received personal fees for participating in steering or data safety monitoring committees from Amgen, Regeneron, Verve Therapeutics, Novo Nordisc, Eli Lilly and Astra Zeneca. A.M.N. has received funding for research to her institution from BMS, Esperion, Amgen, and Janssen, and personal fees from Amarin, Amgen, Astra Zeneca, BI, Bayer, CSL, Esperion, Janssen, Lilly, Sanofi, Regeneron, NovoNordisk, Novartis, New Amsterdam, and Pfizer.

PY - 2022

Y1 - 2022

UR - http://www.scopus.com/inward/record.url?scp=85131527341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131527341&partnerID=8YFLogxK

U2 - 10.1038/s41591-022-01870-8

DO - 10.1038/s41591-022-01870-8

M3 - Article

C2 - 35681104

AN - SCOPUS:85131527341

SN - 1078-8956

JO - Nature medicine

JF - Nature medicine

ER -

A life-course approach to cardiovascular disease prevention

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this